Expression of Hsap\APP695.Scer\UAS.Exel under the control of Scer\GAL4elav-C155 results in age-progressive neurodegeneration as evidenced by the appearance of vacuolar lesions in the adult brain. The adult flies also display age-progressive learning and memory defects in an aversive olfactory memory assay.
Hsap\APP695.UAS.Exel, Scer\GAL4elav-C155 has abnormal neuroanatomy | adult stage | progressive phenotype, non-enhanceable by Hsap\BACE1UAS.cGa, Scer\GAL4elav-C155
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4elav-C155 has abnormal locomotor behavior | adult stage phenotype, suppressible by Hsap\GULP1UAS.cVCa, Scer\GAL4elav-C155
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4elav-C155 has short lived phenotype, suppressible by Hsap\GULP1UAS.cVCa, Scer\GAL4elav-C155
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has decreased cell number | adult stage phenotype, suppressible by Hsap\GULP1UAS.cVCa, Scer\GAL4GMR.PF
Hsap\APP695.UAS.Exel, Scer\GAL4ninaE.PT is an enhancer of decreased cell number | adult stage | progressive phenotype of Hsap\BIN1UAS.1, Scer\GAL4ninaE.PT
Hsap\APP695.UAS.Exel/Scer\GAL4Appl.G1a is a suppressor of abnormal neuroanatomy | third instar larval stage phenotype of SNF4Aγloe
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4elav-C155 has short lived phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has decreased cell number | adult stage phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4elav.PLu has short lived phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4elav.PLu has abnormal eclosion phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has visible | adult stage | progressive phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4elav.Switch.PO has increased rate of movement | adult stage | RU486 conditional phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has visible phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.cGa, Scer\GAL4elav-C155 has abnormal memory | adult stage | progressive phenotype
Hsap\APP695.UAS.Exel, Scer\GAL4elav-C155 has adult brain | progressive phenotype, non-enhanceable by Hsap\BACE1UAS.cGa, Scer\GAL4elav-C155
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has ommatidium phenotype, suppressible by Hsap\GULP1UAS.cVCa, Scer\GAL4GMR.PF
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has rhabdomere phenotype, suppressible by Hsap\GULP1UAS.cVCa, Scer\GAL4GMR.PF
Hsap\APP695.UAS.Exel, Scer\GAL4ninaE.PT is an enhancer of outer photoreceptor cell | adult stage | decreased number phenotype of Hsap\BIN1UAS.1, Scer\GAL4ninaE.PT
Hsap\APP695.UAS.Exel/Scer\GAL4Appl.G1a is a suppressor of larval brain | third instar larval stage phenotype of SNF4Aγloe
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has rhabdomere phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has ommatidium phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has eye | progressive phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has photoreceptor | adult stage | progressive phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has eye phenotype
Hsap\APP695.UAS.Exel, Hsap\BACE1UAS.Exel, Scer\GAL4GMR.PF has retina phenotype
The co-expression of Hsap\BACE1UAS.Exel and Hsap\APP695.UAS.Exel under the control of Scer\GAL4elav-C155 leads to significant decreases in adult climbing ability and in the number of rhabdomere per ommatidium, as compared to controls.
Co-expression of Hsap\APP695.Scer\UAS.Exel and Hsap\BACE1Scer\UAS.Exel under the control of Scer\GAL4GMR.PF results in age-progressive neurodegeneration (retinal collapse) and adult eye morphological defects including dark deposits in the eyes. Co-expression under the Scer\GAL4elav.PLu driver does not affect pupariation rate but significantly decreases the eclosion rate of adult flies, leads to age-progressive deterioration of their climbing abilities and reduces the adult survival rate and median lifespan.
Co-expression of Hsap\APP695.Scer\UAS.Exel and Hsap\BACE1Scer\UAS.Exel driven by Scer\GAL4elav.Switch.PO (with 200um RU486) results in significant hyperactivity (including nocturnal hyperactivity followed by a rapid decline, the effect is more prominent in male flies, and the effect disappears as flies age); this effect is more striking on a diet with a high carbohydrate to protein ratio (compared to low carbohydrate to protein ratio).
Co-expression of Hsap\APP695.Scer\UAS.Exel and Hsap\BACE1Scer\UAS.Exel driven by Scer\GAL4elav-C155 results in significant hypoactivity compared to controls, though total activity at night is not significantly altered (it is significantly decreased during the day).
Co-expression of Hsap\BACE1Scer\UAS.Exel and Hsap\APP695.Scer\UAS.Exel under the control of Scer\GAL4GMR.PF results in a rough eye phenotype with disorganization of the retina, atrophy of ommatidia, and presence of abnormal amyloid deposits, as compared to controls.
Co-expression of Hsap\BACE1Scer\UAS.Exel and Hsap\APP695.Scer\UAS.Exel under the control of Scer\GAL4elav.PLu leads to a significant decrease in lifespan and significant deterioration of climbing ability with age, as compared to controls.
Expression of Hsap\APP695.Scer\UAS.Exel under the control of Scer\GAL4Appl.G1a dramatically suppresses the increase in vacuolisation seen in the brains of SNF4Aγloe mutant third instar larvae.
Co-expression of Hsap\BACE1Scer\UAS.cGa suppresses the increase in vacuolisation seen when Hsap\APP695.Scer\UAS.Exel is expressed in the brains of SNF4Aγloe mutant third instar larvae under the control of Scer\GAL4Appl.G1a.
The loss of tissue due to the age-progressive neurodegeneration (vacuolar lesions) observed in the brains of adult flies expressing Hsap\APP695.Scer\UAS.Exel under the control of Scer\GAL4elav-C155 is not significantly affected by co-expression of Hsap\BACE1Scer\UAS.cGa. Flies expressing Hsap\APP695.Scer\UAS.Exel either alone or in combination with Hsap\BACE1Scer\UAS.cGa display strong age-progressive learning and memory defects.
Made by Exelixis, Inc.